Ulcerative colitis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis

  NCT07302360· Xian-Janssen Pharmaceutical Ltd.· Source

• A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

  NCT07746765· Janssen Sciences Ireland UC· Source

• A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· Janssen Research & Development, LLC· Source

• A Long-term Extension Study of Ustekinumab in Pediatric Participants

  NCT05092269· Janssen Research & Development, LLC· Source

• A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis

  NCT07848737· Janssen-Cilag, S.A.· Source

• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06260163· Janssen Research & Development, LLC· Source

• A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

  NCT07654751· Janssen Research & Development, LLC· Source

• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· Janssen Research & Development, LLC· Source

• A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  NCT06663332· Janssen Research & Development, LLC· Source

• A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis

  NCT07606339· Janssen-Cilag Pharma GmbH· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Organoids 1
• Mendelian Randomization Analysis 4
• Gene Expression Profiling 1
• Sequence Analysis, RNA 1
• Proteomics 2
• Metabolomics 6
• Mass Spectrometry 2
• Flow Cytometry 5
• Immunohistochemistry 14
• Cohort Studies 27
• Genome-Wide Association Study 1

See which targets of this disease your abstract mentions, and go to the people working on them.